Cubist Systematic Strategies’s Genomic Health, Inc. GHDX Stock Holding History

Cubist Systematic Strategies’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,735	Closed	-$321K	–	2661
2019 Q3	$321K	Sell	4,735 -38,887	-89%	-$2.67M	0.01%	1524
2019 Q2	$2.54M	Buy	43,622 +14,289	+49%	+$846K	0.05%	580
2019 Q1	$2.06M	Buy	29,333 +7,698	+36%	+$571K	0.07%	427
2018 Q4	$1.39M	Buy	+21,635	New	+$1.52M	0.07%	422
2018 Q3	–	Sell	-12,511	Closed	-$631K	–	2193
2018 Q2	$631K	Buy	12,511 +10,472	+514%	+$416K	0.03%	679
2018 Q1	$64K	Sell	2,039 -89	-4%	-$2.95K	﹤0.01%	1662
2017 Q4	$73K	Sell	2,128 -2,183	-51%	-$69.6K	﹤0.01%	1738
2017 Q3	$138K	Buy	+4,311	New	+$136K	0.01%	1558

Cubist Systematic Strategies's GHDX Position: Q4 2019 in Review

Cubist Systematic Strategies sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 4,735 shares — an estimated $321K sold.

Cubist Systematic Strategies first reported a position in GHDX in Q3 2017 and held it in 8 quarters. The position peaked at $2.54M in Q2 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Cubist Systematic Strategies reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Cubist Systematic Strategies sold 4,735 Genomic Health, Inc. shares in Q4 2019, an estimated $321K.
Cubist Systematic Strategies first reported a position in Genomic Health, Inc. in Q3 2017 and held it in 8 quarters.
Cubist Systematic Strategies's Genomic Health, Inc. position peaked at $2.54M in Q2 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Cubist Systematic Strategies's 13F filing for Q4 2019, filed 14 Feb 2020.